Pfizer · 14 hours ago
Scientist III
United States - Massachusetts - Andover
Full-time
Onsite
Entry, Mid Level
$83K/yr - $134K/yr
2+ years expPfizer is a leading biopharmaceutical company focused on making a difference in patients' lives. In this role, you will contribute to moderately complex projects related to biopharmaceutical facilities, manage your own work activities, and act as a technical resource for environmental and utility monitoring programs.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
No H1B
Responsibilities
Contribute to the completion of moderately complex projects related to biopharmaceutical facilities, including environmental and utility monitoring programs and cleanroom design
Manage your own time to meet agreed targets; develop plans for short-term work activities on own projects (timelines, work plans, deliverables) within a Work Team
Develop and demonstrate strong knowledge/understanding of the principles, concepts, and compliance requirements set forth by major-market regulatory bodies, Pfizer, and local site standards, relative to biopharmaceutical facilities and utilities
Act as a technical resource for environmental and utility monitoring programs, and cleanroom design. Serve as the chairperson of the environmental review committee
Understand fundamental business drivers such as production plan of record, regulatory compliance, and continuous improvement
Explore and apply enhancements to programs based on efficiencies, risk-based approaches, and changes to pharmaceutical regulations
Make decisions to resolve moderately complex problems in standard situations in support of environmental and utility investigations
Provide feedback on changes to standard methods and techniques when necessary
Work under general supervision with minimal guidance
Uses a variety of communication tools and techniques to troubleshoot difficult issues and works to establish consensus. Tools include Mobile Data Acquisition (MODA), gLIMS, electronic Quality Management System (eQMS), Environmental Monitoring Data Analytics (EMDA)
Author and approve critical documents, Change Controls, and Risk Assessments using PGS Documentation Management System (PDOCs), and eQMS
Present data and program overviews as well as technical rationale during routine quality management reviews, as well as regulatory and corporate audits and inspections
Qualification
Required
Applicant must have a bachelor's degree with at least 2 years of experience; OR a master's degree with 0+ years of experience; OR an associate's degree with 6 years of experience; OR a high school diploma (or equivalent) and 8 years of relevant experience
Demonstrated technical knowledge of biopharmaceutical facility classifications, and monitoring (including critical utilities such as water, steam, and HVAC)
Proven track record of independently accomplishing complex data analyses as well as independent and creative thinking when exploring deviation root-causes
Excellent written and verbal communication skills
Strong interpersonal abilities
Basic computer skills, including data entry and/or verification with a high level of attention to detail
Preferred
Strong background in leading continuous improvement projects
Demonstrated expertise in establishing facility and utility design, classification, and monitoring practices, as well as defending such practices during regulatory audits
Proficiency with common microbial and/or viral inactivation and contamination prevention mechanisms
Familiarity with ICHQ9 and/or risk management tools such as FMEA, RRF, and HAZOP
Experience using common AI tools, including generative technologies such as ChatGPT or Microsoft Copilot, to support problem solving and enhance productivity
Benefits
401(k) plan with Pfizer Matching Contributions
Additional Pfizer Retirement Savings Contribution
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage
Company
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$38BKey Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B
Leadership Team
Albert Bourla
Chief Executive Officer
Ian Read
Chief Executive Officer
Recent News
2026-01-25
Pharma Letter
2026-01-25
Company data provided by crunchbase